id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-327890-ocisq7e4	Pallett, Scott J C	Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study	2020-07-24		.txt	text/plain	5947	271	42	In phase 1, two point-of-care lateral flow serological assays, the Onsite CTK Biotech COVID-19 split IgG/IgM Rapid Test (CTK Bitotech, Poway, CA, USA) and the Encode SARS-CoV-2 split IgM/IgG One Step Rapid Test Device (Zhuhai Encode Medical Engineering, Zhuhai, China), were evaluated for performance against a laboratory immunoassay (EDI Novel Coronavirus COVID-19 IgG ELISA kit [Epitope Diagnostics, San Diego, CA, USA]) in 300 samples from health-care workers and 100 pre-COVID-19 negative control samples. These include point-of-care molecular platforms for acute phase testing, and laboratory ELISA or lateral flow serological assays for antibodies specific to SARS-CoV-2 for delayed case identification. To derive a measure of sensitivity, the results of lateral flow serological assays and ELISA were compared in 300 health-care workers who had previously received PCR testing (AusDiagnostics, Sydney, Australia) at initial presentation with COVID-19 symptoms.	./cache/cord-327890-ocisq7e4.txt	./txt/cord-327890-ocisq7e4.txt